The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.
How Is The Market Size Of The Implantable Infusion Pumps Market Expected To Change From 2026 To 2030?
The implantable infusion pumps market size has experienced significant expansion in recent years. This market is projected to expand from $20.32 billion in 2025 to $21.73 billion in 2026, recording a compound annual growth rate (CAGR) of 6.9%. The growth observed in previous periods can be linked to the increasing occurrence of chronic pain conditions, a growing incidence of diabetes, the rise in oncology treatment procedures, continuous innovations in implantable pump technology, and the development of specialty clinical care services.
The implantable infusion pumps market is anticipated to experience substantial growth in the upcoming years, with its size expected to reach $28.25 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 6.8%. This growth during the forecast period is driven by increasing adoption of smart infusion technologies, rising demand for remote patient monitoring, the expansion of personalized dosing regimens, growing investments in digital therapeutics, and the increasing use of implantable pumps in homecare environments. Major developments expected in this period include the increasing adoption of programmable infusion pumps, a rising demand for long-term pain management solutions, the growing deployment of smart and connected pumps, the expansion of implantable insulin delivery systems, and an enhanced focus on dose accuracy.
Access Your Free Sample Report For In-Depth Market Analysis:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3347&type=smp
What Key Drivers Are Fueling The Growth Of The Implantable Infusion Pumps Market?
A projected rise in the elderly demographic is anticipated to stimulate expansion within the implantable infusion pumps market. This demographic is defined as the proportion of individuals aged 65 and above relative to the employed population aged 18 to 64. The growth of this older demographic stems from extended life expectancies, a consequence of improvements in healthcare and general living conditions, enabling more individuals to live longer lives. Given that implantable infusion pumps are commonly utilized for managing chronic illnesses, an expanding aging population directly translates into a larger base of prospective patients who could benefit from these medical devices. For example, data from Eurostat, the European Union’s statistical office based in Luxembourg, indicated that as of February 2025, the EU’s estimated population in 2024 was around 449 million individuals. Of these, over one-fifth, or 21.6%, were aged 65 and older, and the median age was 44.7 years. Furthermore, the old-age dependency ratio in the EU increased by 0.5 pp between 2023 and 2024, moving from 33.4% to 33.9%. Consequently, the expansion of the aging population is a primary catalyst for the growth experienced in the implantable infusion pumps market.
How Is The Implantable Infusion Pumps Market Organized By Segment Classification?
The implantable infusion pumps market covered in this report is segmented –
1) By Type: Patient-Controlled Analgesia (PCA) Pumps, Enteral Pumps, Insulin Pumps, Elastomeric Pumps, Syringe Pumps, Other Types
2) By Applications: Oncology, Pediatrics Or Neonatology, Gastroenterology, Hematology, Diabetes, Other Applications
3) By End User: Hospitals, Ambulatory Surgical Centers, Specialty Clinics
Subsegments:
1) By Patient-Controlled Analgesia (PCA) Pumps: Morphine PCA Pumps, Fentanyl PCA Pumps, Other Opioid PCA Pumps
2) By Enteral Pumps: Tube Feeding Pumps, Syringe-based Enteral Pumps, Continuous Or Intermittent Feeding Pumps
3) By Insulin Pumps: Insulin Delivery Pumps, Insulin Patch Pumps, Smart Insulin Pumps
4) By Elastomeric Pumps: Disposable Elastomeric Pumps, Reusable Elastomeric Pumps
5) By Syringe Pumps: Small Volume Syringe Pumps, Large Volume Syringe Pumps
6) By Other Types: Chemotherapy Infusion Pumps, Antibiotic Infusion Pumps, Pain Management Pumps
What Trends Are Influencing The Implantable Infusion Pumps Market?
Leading companies in the implantable infusion pumps market are developing new products like insulin pumps to attract broader customer bases, increase sales, and boost revenue. Insulin pumps are medical devices created to help people with diabetes manage their blood sugar levels. For example, in April 2023, Medtronic, an Ireland-based medical device company, announced FDA approval for its MiniMed 780G System, which includes meal detection technology. A distinct feature of this product is its capability to set the lowest glucose target, as low as 100 mg/dL, among all automated insulin pumps currently available, thereby closely emulating the average glucose levels of individuals without diabetes. This setting enables the pump to operate on a treat-to-target approach, automatically adjusting basal insulin and making autocorrections to reach a specific target. Moreover, it is unique as the only pump that features an infusion set designed for comfortable use for an extended period of up to 7 days. This prolonged wear time is achieved by utilizing advanced materials that reduce insulin preservative loss and maintain consistent insulin flow and stability, ultimately decreasing the probability of infusion set occlusion.
Who Are The Industry Participants Involved In The Implantable Infusion Pumps Market?
Major companies operating in the implantable infusion pumps market are Medtronic plc, Boston Scientific Corporation, Baxter International Inc., B. Braun Melsungen AG, Fresenius Kabi AG, Smiths Medical a Smiths Group company, Terumo Corporation, Johnson & Johnson, Greatbatch Medical, Primetech Corporation, Flowonix Medical Inc., F. Hoffmann-La Roche Ltd, Shenzhen Mindray Bio-Medical Electronics Co. Ltd., Micrel Medical, Insulet Corporation, ICU Medical Inc., Becton Dickinson and Company (BD), Roche Diagnostics International AG, Abbott Laboratories, Hospira, Teleflex Incorporated, C. R. Bard Inc., AngioDynamics Inc., Merit Medical Systems Inc., NIPRO Medical Corporation, IRadimed Corporation, Zyno Medical, Tricumed Medizintechnik GmbH, Q Core Medical Ltd., Ivenix Inc., Tandem Diabetes Care Inc.
Get The Full Implantable Infusion Pumps Market Report:
https://www.thebusinessresearchcompany.com/report/implantable-infusion-pumps-global-market-report
Which Region Is The Largest In The Implantable Infusion Pumps Market?
North America was the largest region in the implantable infusion pumps market in 2025. Asia-Pacific was the second-largest region in the implantable infusion pumps market. The regions covered in the implantable infusion pumps market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Request A Customized Implantable Infusion Pumps Market Report For Competitive Insights:
https://www.thebusinessresearchcompany.com/customise?id=3347&type=smp
Browse Through More Reports Similar to the Global Implantable Infusion Pumps Market 2026, By The Business Research Company
Infusion Pump Market Report 2026
https://www.thebusinessresearchcompany.com/report/infusion-pump-global-market-report
Ambulatory Iv Infusion Pumps Market Report 2026
https://www.thebusinessresearchcompany.com/report/ambulatory-iv-infusion-pumps-global-market-report
Intravenous Infusion Pumps Market Report 2026
https://www.thebusinessresearchcompany.com/report/intravenous-infusion-pumps-global-market-report
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model